Stocks Health care MOH
NYSE · Health careMolina Healthcare, Inc. (MOH)
Molina Healthcare, Inc. brought in $44.1B of revenue over the twelve months to September 30, 2026, down 0.9% from a year earlier. It posted a net loss of $48M. In fiscal 2025 capital spending exceeded operating cash flow by $636M. At September 30, 2026 it held $4.5B in cash against $3.8B of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on October 22, 2026.
Key facts about Molina Healthcare, Inc.
- Net worth
- Molina Healthcare, Inc. has a market value (market cap) of $10.7B at the latest share price, and shareholders' equity of $4.2B on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $45.4B (+11.7% year on year), with net income of $472M. Over the 12 months to September 30, 2026: revenue $44.1B, net loss $48M.
- Cash flow
- In fiscal 2025 operations used $535M of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on October 22, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
- Next earnings report
- Molina Healthcare, Inc.'s next report is expected around February 4, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
What Molina Healthcare, Inc. does
Molina Healthcare, Inc. is registered with the SEC under industry code SIC 6324 (Hospital & Medical Service Plans). Its shares trade on NYSE under the ticker MOH.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $45.4B | $472M | $8.92 | -$636M |
| 2024 | $40.7B | $1.2B | $20.42 | $544M |
| 2023 | $34.1B | $1.1B | $18.77 | $1.6B |
| 2022 | $32B | $792M | $13.55 | $682M |
| 2021 | $27.8B | $659M | $11.25 | $2B |
| 2020 | $19.4B | $673M | $11.23 | $1.8B |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where MOH ranks in Health care
Latest SEC filings
What Molina Healthcare, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- November 6, 2026
- October 30, 2026Passive stake changed SCHEDULE 13G/A
- October 27, 2026Passive stake changed SCHEDULE 13G/A
- October 22, 2026Quarterly report 10-Q · period to September 30, 2026Revenue fell 3.4% to $11.1B versus the same quarter last year; diluted EPS $0.73 versus $1.51.
- October 21, 2026
- September 3, 2026Passive stake (5% or more) SCHEDULE 13G
- August 13, 2026Passive stake changed SCHEDULE 13G/A
- August 12, 2026Passive stake changed SCHEDULE 13G/A
- August 6, 2026Passive stake changed SCHEDULE 13G/A
- July 23, 2026Quarterly report 10-Q · period to June 30, 2026Revenue fell 4.8% to $10.9B versus the same quarter last year; diluted EPS $1.19 versus $4.75.
Insider trades
What the people running Molina Healthcare, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider bought or sold shares on the open market in the last 90 days. The 9 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| October 1, 2026 | Brasier Barbara LDirector | Received as pay | 304 | $55K |
| October 1, 2026 | Romney RonnaDirector | Received as payindirect | 304 | $55K |
| October 1, 2026 | Orlando Steven JDirector | Received as payindirect | 304 | $55K |
| October 1, 2026 | Wolf Dale BDirector | Received as payindirect | 304 | $55K |
| October 1, 2026 | Soistman Francis S JrDirector | Received as pay | 304 | $55K |
| October 1, 2026 | Grohowski Leo PDirector | Received as pay | 304 | $55K |
| October 1, 2026 | Zoretic Richard CDirector | Received as payindirect | 304 | $55K |
| October 1, 2026 | Schapiro Richard MDirector | Received as pay | 304 | $55K |
Who owns MOH
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| BlackRock, Inc.13G, passive | 9.2% | October 27, 2026 |
| AQR Capital Management, LLC13G, passive with 1 related filers | 6.83% | August 13, 2026 |
| Vanguard Portfolio Management13G, passive | 5.37% | April 29, 2026 |
| Giovanni Agnelli B.V.13G, passive with 3 related filers | 5.21% | September 3, 2026 |
| Vanguard Capital Management13G, passive | 5.19% | April 30, 2026 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 600 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| BlackRock, Inc. | 6,572,156 | +203,130 |
| Aqr Capital Management LLC | 3,560,601 | +697,208 |
| Vanguard Portfolio Management LLC | 2,790,243 | -728 |
| Capital World Investors | 2,562,913 | -636,433 |
| Lingotto Investment Management LLP | 2,511,490 | new |
| Vanguard Capital Management LLC | 2,355,261 | +45,031 |
| Victory Capital Management Inc | 1,980,615 | -90,084 |
| Fmr LLC | 1,871,290 | -1,333,634 |
| State Street Corp | 1,755,467 | +25,026 |
| Dimensional Fund Advisors LP | 1,393,338 | -1,544 |
| Goldman Sachs Group Inc | 1,306,563 | +579,678 |
| Wellington Management Group Llp | 1,267,207 | +135,247 |
| Two Sigma Investments, LP | 1,266,338 | -84,357 |
| Capital Research Global Investors | 1,092,251 | +4,446 |
| Morgan Stanley | 1,007,068 | +1,071 |
| Harris Associates L P | 957,500 | -20,647 |
| Geode Capital Management, LLC | 891,772 | -29,241 |
| Manning & Napier Advisors LLC | 663,669 | +118,252 |
| UBS Group AG | 624,180 | +151,704 |
| Long Focus Capital Management, LLC | 610,000 | -5,000 |
Insiders
15 insiders reported holding 462,764 shares in total, about $94.8M at the last price.
| Holder | Shares |
|---|---|
| Zubretsky Joseph MPresident & CEO, Director | 99,015 |
| Woys JamesChief Operating Officer | 90,178 |
| Keim Mark LowellChief Financial Officer | 83,251 |
| Barlow Jeff D.Chief Legal Officer | 67,313 |
| Bacon DebraEVP, Medicaid | 21,636 |
| Orlando Steven JDirector | 18,27118,271 held indirectly |
| Romney RonnaDirector | 18,17318,173 held indirectly |
| Wolf Dale BDirector | 15,93715,937 held indirectly |
| Hebert MauriceChief Accounting Officer | 12,815 |
| Schapiro Richard MDirector | 12,615 |
Questions about MOH
What does Molina Healthcare, Inc. do?
Molina Healthcare, Inc. is a company in the Health care sector, listed on NYSE as MOH. Its shares trade on NYSE under the ticker MOH.
What is Molina Healthcare, Inc.'s net worth?
Molina Healthcare, Inc. has a market value (market cap) of $10.7B at the latest share price, and shareholders' equity of $4.2B on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Molina Healthcare, Inc. profitable?
No. Over the twelve months to September 30, 2026 it reported a net loss of $48M on revenue of $44.1B.
How much revenue does Molina Healthcare, Inc. make?
Over the twelve months to September 30, 2026 Molina Healthcare, Inc. reported revenue of $44.1B. That is 0.9% less than a year earlier.
When did Molina Healthcare, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on October 22, 2026. It covers the period to September 30, 2026. Its newest filing of any kind is the investor disclosure from November 6, 2026.
When is Molina Healthcare, Inc.'s next earnings report?
Molina Healthcare, Inc.'s next report is expected around February 4, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare MOH with
Follow MOH
Get an email when Molina Healthcare, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Molina Healthcare, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.